GSK affirms its long-term commitment to manufacturing in Scotland
The new £44 million facility at GSK Montrose will provide ingredients for over 400 million vaccinations a year. Significant investment in recent years re-affirms GSK’s belief that Scotland is an excellent base to manufacture and export to global markets. Built...